Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension

Autoimmunity

Volumn 46, Issue 7, 2013, Pages 463-470

  Arends, Steven J ^a   Damoiseaux, Jan G M C ^b   Duijvestijn, Adriaan M ^a   Debrus Palmans, Lucienne ^a   Boomars, Karin A ^b   Brunner La Rocca, Hans Peter ^a   Cohen Tervaert, Jan Willem ^a   Van Paassen, Pieter ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adhesion molecules; Anti endothelial cell antibodies; Chemokines; Cytokines; Pulmonary arterial hypertension

Indexed keywords

ENDOTHELIAL CELL ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CONTROL; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

AUTOANTIBODIES; COHORT STUDIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; SCLERODERMA, DIFFUSE; SCLERODERMA, SYSTEMIC;

EID: 84885461155     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.812080     Document Type: Article

References (38)

1. Morrell, N. W., S. Adnot, S. L. Archer, et al. 2009. Cellular and molecular basis of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 54(1 Suppl): S20-31.
2. Cool, C. D., S. D. Groshong, J. Oakey, and N. F. Voelkel. 2005. Pulmonary hypertension: cellular and molecular mechanisms. Chest. 128: 565S-571S. (Pubitemid 43054120)
3. Pullamsetti, S. S., R. Savai, W. Janssen, et al. 2011. Inflammation, immunological reaction and role of infection in pulmonary hypertension. Clin. Microbiol. Infect. 17: 7-14.
4. Budhiraja, R., R. Tuder, and P. Hassoun. 2004. Endothelial dysfunction in pulmonary hypertension. Circulation. 109: 159-165. (Pubitemid 38114133)
5. Dama°s, J. K., K. Otterdal, A. Yndestad, et al. 2004. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation. 110: 999-1005. (Pubitemid 39136216)
6. Humbert, M., G. Monti, F. Brenot, et al. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care. Med. 151: 1628-1631.
7. Sanchez, O., E. Marcos, F. Perros, et al. 2007. Role of endotheliumderived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 176: 1041-1047. (Pubitemid 350127849)
8. Dorfmüller, P., F. Perros, K. Balabanian, and M. Humbert. 2003. Inflammation in pulmonary arterial hypertension. Eur. Respir. J. 22: 358-363. (Pubitemid 36987011)
9. Hassoun, P. M., L. Mouthon, J. A. Barberà, et al. 2009. Inflammation, growth factors, and pulmonary vascular remodeling. J. Am. Coll. Cardiol. 54: S10-19.
10. Nicolls, M. R., L. Taraseviciene-Stewart, P. R. Rai, et al. 2005. Autoimmunity and pulmonary hypertension: a perspective. Eur. Respir. J. 26: 1110-1118. (Pubitemid 41829945)
11. Kherbeck, N., M. C. Tamby, G. Bussone, et al. 2013. The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. Clin. Rev. Allergy Immunol. 44: 31-38.
12. Mouthon, L., L. Guillevin, and M. Humbert 2005. Pulmonary arterial hypertension: an autoimmune disease? Eur. Respir. J. 26: 986-988. (Pubitemid 41829926)
13. Belizna, C., A. Duijvestijn, M. Hamidou, and J. W. Tervaert. 2006. Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann. Rheum. Dis. 65: 1545-1550. (Pubitemid 44799663)
14. Belizna, C., and J. W. Cohen Tervaert. 1997. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Semin. Arthritis. Rheum. 27: 98-109. (Pubitemid 27461155)
15. Arends, S. J., J. Damoiseaux, A. Duijvestijn, et al. 2010. Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 35: 923-925.
16. Tamby, M. C., Y. Chanseaud, M. Humbert, et al. 2005. Antiendothelial cell antibodies in idiopathic and systemic sclerosis asscociated pulmonary arterial hypertension. Thorax. 60: 765-772. (Pubitemid 41297897)
17. Bordron, A., R. Révélen, F. D'Arbonneau, et al. 2001. Functional heterogeneity of anti-endothelial cell antibodies. Clin. Exp. Immunol. 124: 492-501. (Pubitemid 32701714)
18. Carvalho, D., C. O. Savage, C. M. Black, and J. D. Pearson. 1996. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J. Clin. Invest. 97: 111-119.
19. Del Papa, N. D., E. Raschi, G. Moroni. 1999. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and proinflammatory phenotype in vitro. Lupus. 8: 423-429. (Pubitemid 29423575)
20. Masi, A., G. Rodman, and T. Medsger. 1980. Preliminary cirteria for the classification of systemic sclerosis (scleroderma). Arthritis. Rheum. 23: 581-590. (Pubitemid 10101764)
21. Tan, E. M., A. S. Cohen, J. F. Fries, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis. Rheum. 25: 1271-1277. (Pubitemid 13221242)
22. LeRoy, E. C., and T. A. Medsger Jr. 2001. Criteria for the classification of early systemic sclerosis. J. Rheumatol. 28: 1573-1576.
23. Barst, R. J., M. McGoon, A. Torbicki, et al. 2004. Diagnosis and differential assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 43: 40S-47S. (Pubitemid 38759716)
24. van Paassen, P., A. Duijvestijn, L. Debrus-Palmans, et al. 2007. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: a potential role for anti-endothelial cell antibodies. Ann. NY Acad. Sci. 1108: 147-156. (Pubitemid 47528728)
25. Andrew, S., and J. Titus. 2001. Fragmentation of immunoglobulin G. Curr. Protoc. Immunol. Chapter 2; Unit 2.8. doi: 10.1002/0471142735.im0208s21.
26. Tamby, M. C., M. Humbert, P. Guilpain, et al. 2006. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur. Respir. J. 28: 799-807. (Pubitemid 46332002)
27. Carvalho, D., and C. Savage. 1997. Cytokines, adhesion molecules, antiendothelial cell autoantibodies and vascular disease. Cardiovasc. Pathol. 6: 61-78. (Pubitemid 27145744)
28. Tuder, R. M., B. Groves, D. B. Badesch, and N. F. Voelkel. 1994. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am. J. Pathol. 144: 275-285. (Pubitemid 24165948)
29. Carvalho, D., C. O. Savage, D. Isenberg, and J. D. Pearson. 1999. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis. Rheum. 42: 631-640. (Pubitemid 29171982)
30. Muller Kobold, A. C., R. T. van Wijk, C. F. Franssen, et al. 1999. In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Clin. Exp. Rheumatol. 17: 433-440. (Pubitemid 29343627)
31. Del Papa, N., L. Guidali, M. Sironi, et al. 1996. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis. Rheum. 39: 758-766. (Pubitemid 26140420)
32. Renaudineau, Y., C. Dugué, M. Dueymes, and P. Youinou. 2002. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun. Rev. 1: 365-372. (Pubitemid 38340250)
33. Furuya, Y., T. Satoh, and M. Kuwana. 2010. Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int. J. Rheumatol. 2010: Article ID 720305 (8 pp.). doi:10.1155/2010/720305.
34. Miyata, M., F. Sakuma, A. Yoshimura, et al. 1995. Pulmonary hypertension in rats. 2. Role of interleukin-6. Int. Arch. Allergy Immunol. 108: 287-291.
35. Ley, K., J. B. Baker, M. I. Cybulsky, et al. 1993. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J. Immunol. 151: 6347-6357. (Pubitemid 23340381)
36. Kimura, H., O. Okada, N. Tanabe. 2001. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am. J. Respir. Crit. Care Med. 164: 319-324. (Pubitemid 34001302)
37. Kimura, H., Y. Kasahara, K. Kurosu, et al. 1998. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab. Invest. 78: 571-581. (Pubitemid 28246981)
38. Kovacs, E. J., and L. A. DiPietro. 1994. Fibrogenic cytokines and connective tissue production. FASEB. J. 8: 854-861. (Pubitemid 24268877)